Maze Therapeutics Inc. (MAZE)
NASDAQ · Healthcare
Maze Therapeutics Inc. Income Statement 2024–2024
| Dec 2024 | |
|---|---|
| Revenues | |
| Revenue | 167.5M |
| Gross Profit | — |
| Profitability | |
| Operating Income | 57.6M |
| EBITDA | — |
| Net Income | 52.2M |
| Per Share Data | |
| EPS (diluted) | $1.25 |
| Shares Outstanding (dil.) | 3M |
Maze Therapeutics Inc. Income Statement — FAQ
Maze Therapeutics Inc. (MAZE) income statement over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MAZE's income statement history?
The chart and table above show Maze Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.